Data / Form D filings / Gliknik Inc
Gliknik Inc: Form D filings
Gliknik Inc, a biotechnology company in Baltimore, MD, filed 17 Form D notices with the SEC between 2009 and 2026. The latest, on September 17, 2026, reports $15 million sold of a $15 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 801 WEST BALTIMORE STREET SUITE 501A, Baltimore, MD, 21201
- Phone
- (410) 685-0662
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1411569
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Amendment | $15,000,000 | $15,000,000 | 11 | Aug 15, 2025 | sec.gov | |
| Aug 21, 2025 | New notice | $15,000,000 | $11,000,000 | $4,000,000 | 9 | Aug 15, 2025 | sec.gov |
| Jan 24, 2025 | Amendment | $6,000,000 | $5,286,743 | $713,257 | 25 | Nov 6, 2024 | sec.gov |
| Nov 21, 2024 | New notice | $5,000,000 | $2,000,000 | $3,000,000 | 1 | Nov 6, 2024 | sec.gov |
| Mar 21, 2024 | Amendment | $16,200,000 | $9,175,302 | $7,024,698 | 23 | Jun 29, 2023 | sec.gov |
| Jul 7, 2023 | New notice | $16,200,000 | $5,380,000 | $10,820,000 | 17 | Jun 29, 2023 | sec.gov |
| Jun 2, 2021 | New notice | $12,000,003 | $4,300,005 | $7,699,998 | 4 | May 20, 2021 | sec.gov |
| Sep 12, 2013 | New notice | $5,000,000 | $2,835,000 | $2,165,000 | 13 | Sep 3, 2013 | sec.gov |
| Apr 30, 2013 | Amendment | $15,000,000 | $9,900,015 | $5,099,985 | 27 | Aug 13, 2012 | sec.gov |
| Apr 26, 2013 | Amendment | $15,000,000 | $9,825,014 | $5,174,986 | 26 | Aug 13, 2012 | sec.gov |
| Aug 27, 2012 | New notice | $15,000,000 | $4,825,010 | $10,174,990 | 24 | Aug 13, 2012 | sec.gov |
| Sep 6, 2011 | New notice | $2,328,552 | $2,038,552 | $290,000 | 21 | Aug 24, 2011 | sec.gov |
| Jan 4, 2011 | New notice | $3,900,000 | $849,605 | $3,050,395 | 6 | Dec 21, 2010 | sec.gov |
| Sep 3, 2010 | Amendment | $4,000,000 | $2,400,000 | $1,600,000 | 15 | Aug 17, 2010 | sec.gov |
| Aug 30, 2010 | New notice | $4,000,000 | $1,900,000 | $2,100,000 | 14 | Aug 17, 2010 | sec.gov |
| Jan 13, 2010 | Amendment | $3,612,500 | $2,887,515 | $724,985 | 23 | Aug 19, 2008 | sec.gov |
| Sep 1, 2009 | Amendment | $3,612,500 | $2,887,515 | $724,985 | 23 | Aug 19, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David S. Block | Executive Officer, Director | |
| Charles Polsky | Director | |
| Kyle Rusconi | Director | |
| Raymond Schinazi | Director | |
| Richard S. Levy | Director | |
| Paul Freidman | Director | |
| Elizabeth Block | Executive Officer | |
| David Broser | Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Sep 14, 2026 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Gliknik Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.